Gritstone bio Granted Two New U.S. Patents for Self-amplifying mRNA (samRNA)

December 13, 2022

https://www.globenewswire.com/news-release/2022/12/13/2572523/0/en/Gritstone-bio-Granted-Two-New-U-S-Patents-for-Self-amplifying-mRNA-samRNA.html

EMERYVILLE, Calif., Dec. 13, 2022 (GLOBE NEWSWIRE) — Gritstone bio, Inc. (Nasdaq:GRTS), a clinical-stage biotechnology company working to develop the world’s most potent vaccines, today announced that the United States Patent and Trademark Office (USPTO) recently issued two new patents related to the company’s novel self-amplifying mRNA (samRNA) vaccine platform technology.

Read more at globenewswire.com

Related news for (GRTS)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.